Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Ueda

Showing results (321-330 of 359) with videos related to

Pageof 36
Sort By:
Oncogene|March 3, 2020
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovaryRyo Tamura, Kosuke Yoshihara, Hirofumi Nakaoka, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2023
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutationsTakashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, et al.
Chest|May 11, 2019
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, et al.
Cancer Letters|February 7, 2006
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatinYuko Ueno, Takayuki Enomoto, Yoshiro Otsuki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian CancerSumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, et al.
Cancer Science|February 26, 2022
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinomaTomomi Egawa-Takata, Yutaka Ueda, Kimihiko Ito, et al.
Cancers|January 8, 2023
Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive RadiotherapyAiri Kuruma, Michiko Kodama, Yumiko Hori, et al.
The American Journal of Pathology|December 16, 2023
Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine CervixMasamune Masuda, Keita Iida, Sadahiro Iwabuchi, et al.
International Journal of Clinical Oncology|July 9, 2014
Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccinationAkiko Morimoto, Yutaka Ueda, Tomomi Egawa-Takata, et al.
International Journal of Clinical Oncology|March 13, 2016
Mothers' attitudes in Japan regarding cervical cancer screening correlates with intention to recommend cervical cancer screening for daughtersTomomi Egawa-Takata, Yutaka Ueda, Yusuke Tanaka, et al.
Pageof 36

Showing results (321-330 of 359) with videos related to

Sort By:
Pageof 36
Oncogene|March 3, 2020
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovaryRyo Tamura, Kosuke Yoshihara, Hirofumi Nakaoka, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2023
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutationsTakashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, et al.
Chest|May 11, 2019
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, et al.
Cancer Letters|February 7, 2006
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatinYuko Ueno, Takayuki Enomoto, Yoshiro Otsuki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian CancerSumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, et al.
Cancer Science|February 26, 2022
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinomaTomomi Egawa-Takata, Yutaka Ueda, Kimihiko Ito, et al.
Cancers|January 8, 2023
Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive RadiotherapyAiri Kuruma, Michiko Kodama, Yumiko Hori, et al.
The American Journal of Pathology|December 16, 2023
Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine CervixMasamune Masuda, Keita Iida, Sadahiro Iwabuchi, et al.
International Journal of Clinical Oncology|July 9, 2014
Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccinationAkiko Morimoto, Yutaka Ueda, Tomomi Egawa-Takata, et al.
International Journal of Clinical Oncology|March 13, 2016
Mothers' attitudes in Japan regarding cervical cancer screening correlates with intention to recommend cervical cancer screening for daughtersTomomi Egawa-Takata, Yutaka Ueda, Yusuke Tanaka, et al.
Pageof 36